- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Sep 14, 2023
Distillery Therapeutics
Inhibition of calprotectin for vascular calcification in chronic kidney disease
BioCentury | Oct 25, 2019
Product Development
Lykera takes aim at aggressive cancers by targeting pre-metastatic niche
Lykera's mAbs target S100 proteins implicated in driving cancer metastases
BioCentury | Sep 10, 2019
Distillery Therapeutics
S100A9 could normalize metabolic imbalances from insulin deficiency
Items per page:
1 - 10 of 67